Business
Currency:HKD
2024/H1
Stock NameRevenueRatio
药物和医疗科技业务136.7M87.58%
Chinese medicine business12.42M7.96%
医疗和保健服务6.95M4.46%
Product
Currency:HKD
2018/FY
Stock NameRevenueRatio
Brain protein hydrolysate for injection158.27M43.77%
Other products81.37M22.50%
托恩(布洛芬混悬液及滴剂)65.29M18.06%
托平(缬沙坦胶囊)56.63M15.66%
Region
Currency:HKD
2024/H1
Stock NameRevenueRatio
Chinese mainland152.17M97.50%
Hong Kong3.38M2.17%
Australia526K0.34%